Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Carrillo

Showing results (71-80 of 242) with videos related to

Pageof 25
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2015
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in NeurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumKonstantinos Chiotis, Ganna Blazhenets, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometryJosef Pannee, Johan Gobom, Leslie M Shaw, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2011
Global issues in drug development for Alzheimer's diseaseRachelle S Doody, Patricia E Cole, David S Miller, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisJeff Katula, Jennifer Ventrelle, Sarah Graef, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 15, 2018
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's diseaseLeslie M Shaw, Jalayne Arias, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 1, 2013
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers ConsortiumMaria C Carrillo, Kaj Blennow, Holly Soares, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2023
Decision making in clinical trials: Interim analyses, innovative design, and biomarkersKathleen A Welsh-Bohmer, Geoffrey A Kerchner, Shobha Dhadda, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Beyond amyloid: getting real about nonamyloid targets in Alzheimer's diseaseKarl Herrup, Maria C Carrillo, Dale Schenk, et al.
Pageof 25

Showing results (71-80 of 242) with videos related to

Sort By:
Pageof 25
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2015
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in NeurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumKonstantinos Chiotis, Ganna Blazhenets, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometryJosef Pannee, Johan Gobom, Leslie M Shaw, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2011
Global issues in drug development for Alzheimer's diseaseRachelle S Doody, Patricia E Cole, David S Miller, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisJeff Katula, Jennifer Ventrelle, Sarah Graef, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 15, 2018
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's diseaseLeslie M Shaw, Jalayne Arias, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 1, 2013
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers ConsortiumMaria C Carrillo, Kaj Blennow, Holly Soares, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2023
Decision making in clinical trials: Interim analyses, innovative design, and biomarkersKathleen A Welsh-Bohmer, Geoffrey A Kerchner, Shobha Dhadda, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Beyond amyloid: getting real about nonamyloid targets in Alzheimer's diseaseKarl Herrup, Maria C Carrillo, Dale Schenk, et al.
Pageof 25